SCHEMBL4201646

SCHEMBL4201646

CCCCCCC(CCCCCCCCCCC(=O)OC(CCCCCC)CCCCCCCCCCC(=O)O)OC(=O)CC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 5/20 0.58
MAPT P10636 4/20 0.58
FFAR4 Q5NUL3 2/20 0.56
FFAR1 O14842 2/20 0.56
LMNA P02545 4/20 0.55
ALDH1A1 P00352 3/20 0.55
TSHR P16473 5/20 0.55
GMNN O75496 3/20 0.55
NPSR1 Q6W5P4 3/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
CYP1A2 P05177 2/20 0.55
HSP90AA1 P07900 2/20 0.55
BLM P54132 2/20 0.55
NR1H4 Q96RI1 2/20 0.55
TP53 P04637 1/20 0.55
CYP2C9 P11712 1/20 0.55
HIF1A Q16665 1/20 0.55
GLA P06280 1/20 0.54
PMP22 Q01453 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4204493 0.97 FFAR4 (0.59) MAPK1MAPTFFAR4FFAR1LMNA
SCHEMBL215669 0.95 MAPK1 (0.64) MAPK1MAPTFFAR4FFAR1LMNA
SCHEMBL6843599 0.95 MAPK1 (0.64) MAPK1MAPTFFAR4FFAR1LMNA
SCHEMBL2154198 0.95 MAPK1 (0.64) MAPK1MAPTFFAR4FFAR1LMNA
SCHEMBL23288413 0.95 MAPK1 (0.64) MAPK1MAPTFFAR4FFAR1LMNA
SCHEMBL25297686 0.95 MAPK1 (0.64) MAPK1MAPTFFAR4FFAR1LMNA
SCHEMBL23860683 0.95 MAPK1 (0.64) MAPK1MAPTFFAR4FFAR1LMNA
SCHEMBL23565739 0.95 MAPK1 (0.64) MAPK1MAPTFFAR4FFAR1LMNA
SCHEMBL22589987 0.95 MAPK1 (0.64) MAPK1MAPTFFAR4FFAR1LMNA
Myristic Acid SCHEMBL9408104 0.95 MAPK1 (0.64) MAPK1MAPTFFAR4FFAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7491836-B2 Non-ionic surfactants for poorly soluble molecules ASTRAZENECA AB (SE) 2009-02-17 US disclosed
US-20060287542-A1 Non-ionic surfactants for solubilizing poorly solubule molecules ASTRAZENECA AB (SE) 2006-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287542-A1 Non-ionic surfactants for solubilizing poorly solubule molecules LIPA, ELOVL1, FASN MAPK1 3146/4885MAPT 4810/4885FFAR4 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.